Drug profile · INN
sonidegib
ODOMZO
sonidegib (ODOMZO) is a smoothened homolog inhibitor. Associated with Lacuna Pharma Pty Ltd.
EMA: approved TGA: approved Antineoplastic and immunomodulating agents (L01) L01XJ02
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — sonidegib
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
sonidegib (ODOMZO) is a smoothened homolog inhibitor. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN sonidegib
Brand ODOMZO
Mechanism Smoothened homolog inhibitor
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XJ02
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Smoothened homolog inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is sonidegib?
sonidegib (ODOMZO) is a smoothened homolog inhibitor. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for sonidegib?
ODOMZO is a marketed brand name for sonidegib. Check FDA Drugs@FDA for the current US label holder and prescribing information.